Cure8 research brief
Why This Matters
The study suggests molecular targets and pathways through which a traditional herbal formula might influence UC biology, offering testable hypotheses for future lab and clinical research.
Who Should Pay Attention
Researchers, clinicians, and drug-discovery teams interested in herbal medicines, molecular mechanisms of UC, or multi-target therapeutic strategies.
Study Snapshot
What To Know
The paper screened active compounds from SKD and predicted 94 shared targets between SKD and UC. Key hub proteins included AKT1, TNF, and TP53, and pathway analysis highlighted PI3K‑Akt and MAPK signaling.
Molecular docking and 100‑ns molecular dynamics simulations suggested stable binding for some compound–target pairs (for example, kaempferol with TNF and β‑sitosterol with AKT1) while others were less stable.
These results are computational and hypothesis-generating: they propose molecular interactions and pathways that might explain SKD's reported effects but do not provide clinical evidence of efficacy or safety.
Keep In Mind
Results are from computational analyses (network pharmacology, molecular docking, molecular dynamics). They do not demonstrate clinical benefit or safety and require experimental and clinical validation.
Source Details
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.